Balance sheet of Alivus Life Sciences is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Alivus Life Sciences is increasing.
Latest net debt of Alivus Life Sciences is -₹142.46 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹603.15 Crs.

Yes, profit is increasing.
The profit of Alivus Life Sciences is ₹496 Crs for TTM, ₹486 Crs for Mar 2025 and ₹471 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Alivus Life Sciences latest dividend payout ratio is 12.62% and 3yr average dividend payout ratio is 42.09%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Accounts Receivable